化合物AZD4320 T14376
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 1357576-48-7 | ¥4,920.00 | 询底价 |
100 mg | 1357576-48-7 | ¥6,890.00 | 询底价 |
1 mg | 1357576-48-7 | ¥549.00 | 询底价 |
5 mg | 1357576-48-7 | ¥1,390.00 | 询底价 |
25 mg | 1357576-48-7 | ¥3,230.00 | 询底价 |
1 mL | 1357576-48-7 | ¥2,090.00 | 询底价 |
10 mg | 1357576-48-7 | ¥1,970.00 | 询底价 |
2 mg | 1357576-48-7 | ¥823.00 | 询底价 |
Product Introduction
Bioactivity
英文名: AZD4320
描述: AZD4320 是一种BCL2/BCLxL 双重抑制剂,是 BH-3 类似物,对 KPUM-MS3、KPUM-UH1 和 STR-428 细胞,IC50 值分别为 26 nM、17 nM 和 170 nM。
体外活性: AZD4320 shows mostly synergistic, and at least additive, growth inhibitory effects on DEL- and DHL derived cell lines. And it profoundly increases cells undergoing apoptosis in all three cell lines[1]. AZD4320 potently augments the antitumor effect of AZD5153 in double expressing lymphoma (DEL)- and double hit lymphoma (DHL)-derived cell lines in a dose-dependent manner.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 125 mg/mL (132.20 mM)
关键字: Bcl-2 Family | Inhibitor | AZD4320 | AZD 4320 | inhibit | AZD-4320
相关产品: IVHD-valtrate | Bcl-xL antagonist 2 | 2-Methoxystypandrone | (S)-Purvalanol B | WEHI-9625 | TC11 | S55746 hydrochloride | Hinokiflavone | Navitoclax | Paederosidic acid
相关库: Anti-Cancer Compound Library | Bioactive Compounds Library Max | Anti-Lung Cancer Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | Apoptosis Compound Library | Cuproptosis Compound Library | Preclinical Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物AZD4320 T14376信息由TargetMol中国为您提供,如您想了解更多关于化合物AZD4320 T14376报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途